KNSA (kiniksa.com) Bozor qiymatining balans qiymatiga nisbati
Kiniksa Pharmaceuticals (KNSA) kompaniyasining narxlar dinamikasida aks etgan bozor harakatlari 10.58 darajasidagi ko'rsatkichlarni namoyish etmoqda. Biznes yangi immun agentlarini ishlab chiqishga e'tibor qaratish uchun molekulalar va testlar ishlab chiqarishni tashqi pudratchilarga autsorsing qilishga tayanadi. Kardiologiya sohasidagi global sanoat yetakchilari bilan hamkorlik orqali samaradorlik oshirilmoqda, og'ir yallig'lanishlarning noyob terapiya usullari tufayli esa daromadlilik o'sib bormoqda.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_KNSA_-_Kiniksa-Pharmaceuticals_-_Market-Capitalization-to-Net-Assets "KNSA Kiniksa Corp Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 29.10.2026) | 👁️GURU.Markets👁️")
Kiniksa Pharmaceuticals, Ltd. (KNSA) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Kiniksa Pharmaceuticals|KNSA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Kiniksa Pharmaceuticals Ltd|KNSA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Kiniksa Pharmaceuticals Ltd|KNSA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Kiniksa
Kompaniyaning dastlabki tahlili:Kiniksa Pharmaceuticals - KNSA
Kiniksa Pharmaceuticals (KNSA) kompaniyasining tor terapevtik nishalardagi kuchli narx belgilash imkoniyati uning sof aktivlar qiymatidan sezilarli darajada yuqori bozor premiumini yaratadi, bu esa eksklyuziv dori huquqlariga oid investorlar kutishlarini aks ettiradi. Bozor kapitalizatsiyasining balans qiymatiga nisbatidagi o'zgarishlarni tahlil qilish ushbu premiumning tebranishlarini baholash imkonini beradi va kompaniyaning joriy bozor qiymati qanchalik darajada uning haqiqiy aktivlar bazasi bilan ta'minlanganligini aniqlaydi.
Asosiy raqobatchilar
ARGX: Bozor kapitallashuvining balans qiymatiga nisbati|BNTX (biontech.de) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati GRFS (Grifols, S.A.)|adaptivebiotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Celldex Therapeutics, Inc. (CLDX)|AUPH: Balans qiymatiga nisbatan bozor qiymati|BCRX (BioCryst Pharmaceuticals Inc) - Bozor qiymatining balans qiymatiga nisbati|Vera Corp (VERA) - Kapitallashuvning sof aktivlarga nisbati|DNTH (Dianthus Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pharvaris.com (PHVS)|AbCellera Bio (ABCL) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Tourmaline Bio Inc (TRML)|Bozor kapitallashuvining balans qiymatiga nisbati PGEN|Pharming Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|NKTR: Bozor qiymatining balans qiymatiga nisbati|UPB: Kapitallashuvning sof aktivlarga nisbati|ZBIO (Zenas Biopharma) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Immunome Inc|GOSS (Gossamer Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati KALV|Bozor qiymatining balans qiymatiga nisbati Septerna Inc SEPN|Kapitallashuvning balans qiymatiga nisbati pieris.com (PVLA)|SVRA: Bozor kapitallashuvining balans qiymatiga nisbati|Rigel Pharma - Bozor qiymatining balans qiymatiga koeffitsiyenti|AnaptysBio Corp - Bozor qiymatining balans qiymatiga nisbati|ATXS - Bozor kapitallashuvining balans qiymatiga nisbati|enGene Holdings Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|RAPT (rapt.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Aerovate Therapeutics, Inc. (JBIO)|Kapitallashuvning balans qiymatiga nisbati Aclaris Therapeutics Inc.|KYTX (Kyverna) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi TLSA (Tiziana Life Sciences, Ltd.)|Bozor qiymatining balans qiymatiga nisbati CABA (Cabaletta Bio, Inc.)|ventyxbio.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati THTX (Theratechnologies)|AVTX - Balans qiymatiga nisbatan bozor kapitallashuvi|ELDN: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Agenus, Inc|CLYM - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati ZURA|ATYR - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi adagene.com (ADAG)|Bozor kapitallashuvining balans qiymatiga nisbati Ikena Oncology|Balans qiymatiga nisbatan bozor qiymati Shattuck Labs Inc STTK|Equillium Bio - Bozor kapitallashuvining balans qiymatiga nisbati|CNTB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati immunic-therapeutics.com IMUX|ATRA (Atara Bio) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati IFRX|Kapitallashuvning sof aktivlarga nisbati X4 Pharmaceuticals, Inc|Bozor kapitallashuvining balans qiymatiga nisbati ACET|Bozor kapitallashuvining balans qiymatiga nisbati celularity.com (CELU)|INmune Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Barinthus Biotherapeutics PLC BRNS|KZR (Kezar Life Sciences, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|SAB Biotherapeutics Inc (SABS) - Bozor qiymatining balans qiymatiga koeffitsiyenti|AKTX: Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Enlivex Therapeutics Ltd.|Q32 Bio Inc (QTTB) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori GeoVax Labs|EDSA (Edesa) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi iBio Corporation (IBIO)|Carisma Therapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati xtlbio.com XTLB|Bolt Bio - Bozor kapitallashuvining balans qiymatiga nisbati|HCWB: Bozor kapitallashuvining balans qiymatiga nisbati|aptevotherapeutics.com (APVO) - Bozor qiymatining balans qiymatiga nisbati|AIM (aimimmuno.com) - Bozor qiymatining balans qiymatiga nisbati|ADTX: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi GRI|Bozor qiymatining balans qiymatiga nisbati XRTX|Bozor kapitallashuvining balans qiymatiga nisbati HIND (Vyome Holdings Inc.)|REVB - Bozor qiymatining balans qiymatiga nisbati|Indaptus Corp - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati SCNI (Scinai Immunotherapeutics)|CALI - Balans qiymatiga nisbatan bozor kapitallashuvi|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|ALLK (Allakos) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati HOOKIPA Pharma, Inc. HOOK|Sof aktivlarga nisbatan bozor kapitallashuvi IGM Bio|iTeos Therapeutics (ITOS) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|Third Harmonic Bio Inc. - Bozor kapitallashuvining balans qiymatiga nisbati